The Medical Research Agency (ABM) selected a Medical University of Warsaw (MUW) research project in a competition for research and development in non-commercial clinical trials. The research project “EMpagliflozin and daPAgliflozin in patients hospiTalized for acute decompensated Heart failure (EMPATHY trial)” initiated by MUW scientists will receive funding in the amount of 30 084 379.80PLN.
